市場調查報告書
商品編碼
1267486
拉丁美洲皮下注射器和針頭市場——按類型、使用性別、最終用途、全球預測,2023-2032 年Latin America Hypodermic Syringes & Needles Market - By Type, By Usability, By Application, By End-use, & Global Forecast, 2023 - 2032 |
由於在拉丁美洲經濟體中進行的手術數量不斷增加,預計從 2023 年到 2032 年,拉丁美洲皮下注射和針頭市場將遵循積極的軌跡。
一份報告顯示,2020 年,巴西小靈通因外科手術住院的人數超過 400 萬。
隨著老年人口的不斷增長,我們看到對改善生活質量的外科手術的需求不斷增加。 技術創新還促進了在治療相關疾病方面安全、無菌和微創針頭外科手術的發展。
總體而言,拉丁美洲皮下注射器和針頭行業在類型、可用□□性、應用、最終用途和地區方面進行了細分。
按類型劃分,由於人們對通過注射器進行藥物治療的意識不斷增強,預計注射器細分市場將從 2023 年到 2032 年出現增長。 此外,拉美各國政府實施的關於使用無菌一次性注射器的幾項安全指南得到了醫療保健行業主要參與者的大力支持。
可重複使用的皮下注射器和針頭具有多重優勢,例如價格實惠、質量高、抗拉強度高和更清潔的環境足跡,因此在未來十年可以使用的地方它們將引起極大興趣。將收集 此外,到 2032 年,環保消耗品和減少浪費等產品優勢將刺激該行業的增長。
根據應用,血液採集行業預計到 2032 年的複合年增長率將超過 3.5%。 預計拉丁美洲地區獻血和血小板輸注運動的顯著改善將對該領域的前景產生積極影響。
考慮到最終用途,到 2032 年,診斷中心行業的價值可能超過 940 億美元。 呼吸系統疾病、血液相關疾病、糖尿病和高血壓的增加預計將在未來幾年增加對此類中心的需求。 由於慢性疾病的增加,血液和標本採集量的增加預計將在未來幾年進一步使這些設施受益。
按國家/地區劃分,墨西哥皮下注射器和針頭市場預計在預測期內將出現顯著增長。 技術進步、醫療保健支出增加和人口迅速老齡化等因素將影響該地區的收入份額。 此外,醫療保健設施、診斷治療和慢性病的增長預計將推動該國的增長。
Latin America Hypodermic Syringes & Needles Market is estimated to depict a positive trajectory during 2023-2032, owing to the increasing number of surgeries taking place in the Latin American economies. As per reports, there were more than 4 million hospitalizations for surgical procedures in the Brazilian PHS in 2020.
Constantly rising geriatric population has been witnessing a growing demand for surgical procedures to improve the quality of life. Besides, technological innovations have favored the evolution of surgical procedures that incorporate safe, sterile, and less invasive needles in treating related ailments.
Overall, the Latin America Hypodermic Syringes & Needles industry is segmented in terms of type, usability, application, end-use and region.
Based on type, the syringes segment will demonstrate growth during 2023-2032 owing to the increasing awareness regarding administering medications using syringes. Besides, the key players operating in the healthcare business space are gaining huge traction owing to several safety guidelines imposed by various LATAM governments regarding the use of sterile single-use syringes.
By usability, the reusable segment will gain huge prominence over the next decade owing to the multiple advantages offered by reusable hypodermic syringes and needles such as affordability, high quality, tensile strength, and a cleaner environmental footprint. In addition, product benefits such as environment-friendly supplies and less waste creation will spur the segment growth by 2032.
In terms of application, the blood collection segment will exhibit over 3.5% CAGR through 2032. Significant improvement in blood donations & platelet transfusion campaigns in the Latin America region will positively influence the segmental outlook.
Considering the end-use, the diagnostic centers segment will be valued at over USD 94 billion by 2032. Increasing incidences of respiratory disorders, blood-related diseases, diabetes, and hypertension will spur the demand for such centers over the coming years. The increased blood & specimen collection volume due to rising cases of chronic illnesses is further set to benefit these facilities in the coming years.
Country-wise, the Mexico hypodermic syringes & needles market will record substantial growth during the forecast spell. Factors such as increasing modern technologies, rising healthcare expenditures, and a rapidly ageing population will influence the regional revenue share. Besides, the increasing number of healthcare facilities, diagnostic therapy, and chronic diseases will boost the country growth.